The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nomenclature of Voltage-Gated Sodium Channels
Goldin, A. L., Barchi, R. L., Caldwell, J. H., Hofmann, F., Howe, J. R., Hunter, J. C., Kallen, R. G., Mandel, G., Meisler, M. H., Netter, Y. B., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)00116-1 · Cited by 1,481
Self-citationNomenclature of Voltage-Gated Calcium Channels
Ertel, E. A., Campbell, K. P., Harpold, M. M., Hofmann, F., Mori, Y., Perez-Reyes, E., Schwartz, A., Snutch, T. P., Tanabe, T., Birnbaumer, L., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)81057-0 · Cited by 885
Self-citation
Cited by
Items 301–400 of 559
Estrogen Receptor β: An Overview and Update
Zhao, C., Dahlman-Wright, K., & Gustafsson, J.-Å. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06003 · Cited by 309
Molecular physiology and modulation of somatodendritic A-type potassium channels
Jerng, H. H., Pfaffinger, P. J., & Covarrubias, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.06.011 · Cited by 308
Immunomodulatory and neuroprotective effects of inosine
Haskó, G., Sitkovsky, M. V., & Szabó, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.006 · Cited by 308
Adenosine signaling and function in glial cells
Boison, D., Chen, J.-F., & Fredholm, B. B. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.131 · Cited by 306
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more
Ramachandran, R., & Hollenberg, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707507 · Cited by 305
Barton, M., & Yanagisawa, M. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-059 · Cited by 305
Chemokine receptor antagonists: overcoming developmental hurdles
Horuk, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2734 · Cited by 303
Endocannabinoid-Mediated Metaplasticity in the Hippocampus
Chevaleyre, V., & Castillo, P. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.036 · Cited by 302
The chemokine receptor D6 limits the inflammatory response in vivo
Jamieson, T., Cook, D. N., Nibbs, R. J. B., Rot, A., Nixon, C., Mclean, P., Alcami, A., Lira, S. A., Wiekowski, M., & Graham, G. J. (2005) · Nature Immunology · doi:10.1038/ni1182 · Cited by 302
Involvement of functional autoantibodies against vascular receptors in systemic sclerosis
Riemekasten, G., Philippe, A., Näther, M., Slowinski, T., Müller, D. N., Heidecke, H., Matucci-Cerinic, M., Czirják, L., Lukitsch, I., Becker, M., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135772 · Cited by 302
Michel, M. C., Foster, C., Brunner, H. R., & Liu, L. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007278 · Cited by 301
Interplay between Cartilage and Subchondral Bone Contributing to Pathogenesis of Osteoarthritis
Sharma, A., Jagga, S., Lee, S.-S., & Nam, J.-S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019805 · Cited by 301
Dai, Y., Moriyama, T., Higashi, T., Togashi, K., Kobayashi, K., Yamanaka, H., Tominaga, M., & Noguchi, K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0454-04.2004 · Cited by 301
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Torres, S., Lorente, M., Rodríguez-Fornés, F., Hernández-Tiedra, S., Salazar, M., García-Taboada, E., Barcia, J., Guzmán, M., & Velasco, G. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0688 · Cited by 301
Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain
Müller, C. S., Haupt, A., Bildl, W., Schindler, J., Knaus, H.-G., Meissner, M., Rammner, B., Striessnig, J., Flockerzi, V., Fakler, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005940107 · Cited by 301
Craft, R. M., Marusich, J. A., & Wiley, J. L. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.009 · Cited by 299
Langford, R. M., Mares, J., Novotna, A., Vachova, M., Novakova, I., Notcutt, W., & Ratcliffe, S. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6739-4 · Cited by 298
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
Maccarrone, M., Guzmán, M., Mackie, K., Doherty, P., & Harkany, T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3846 · Cited by 298
Gever, J. R., Cockayne, D. A., Dillon, M. P., Burnstock, G., & Ford, A. P. D. W. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0070-9 · Cited by 298
Contribution of Calcium Ions to P2X Channel Responses
Egan, T. M., & Khakh, B. S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5429-03.2004 · Cited by 296
The enigmatic pharmacology of GPR55
Ross, R. A. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.004 · Cited by 296
Arterial Response to Shear Stress Critically Depends on Endothelial TRPV4 Expression
Hartmannsgruber, V., Heyken, W.-T., Kacik, M., Kaistha, A., Grgic, I., Harteneck, C., Liedtke, W., Hoyer, J., & Köhler, R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000827 · Cited by 295
Chemokine receptors: signposts to brain development and disease
Tran, P. B., & Miller, R. J. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1116 · Cited by 295
Loss-of-function mutations in sodium channel Nav1.7 cause anosmia
Weiss, J., Pyrski, M., Jacobi, E., Bufe, B., Willnecker, V., Schick, B., Zizzari, P., Gossage, S. J., Greer, C. A., Leinders-Zufall, T., et al. (2011) · Nature · doi:10.1038/nature09975 · Cited by 294
Chen, M., Tao, L., McLean, J., & Lu, C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf501397m · Cited by 294
Cannabinoid receptors as novel targets for the treatment of melanoma
Blázquez, C., Carracedo, A., Barrado, L., José Real, P., Luis Fernández‐Luna, J., Velasco, G., Malumbres, M., Guzmán, M., Blázquez, C., Carracedo, A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6638fje · Cited by 292
Németh, Z. H., Lutz, C. S., Csóka, B., Deitch, E. A., Leibovich, S. J., Gause, W. C., Tone, M., Pacher, P., Vizi, E. S., & Haskó, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8260 · Cited by 291
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Le Foll, B., & Goldberg, S. R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 291
The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes
Ulvmar, M. H., Werth, K., Braun, A., Kelay, P., Hub, E., Eller, K., Chan, L., Lucas, B., Novitzky-Basso, I., Nakamura, K., et al. (2014) · Nature Immunology · doi:10.1038/ni.2889 · Cited by 290
Furusato, B., Mohamed, A., Uhlén, M., & Rhim, J. S. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02548.x · Cited by 290
Age-associated chronic diseases require age-old medicine: Role of chronic inflammation
Prasad, S., Sung, B., & Aggarwal, B. B. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2011.11.011 · Cited by 290
Quinn, H. R., Matsumoto, I., Callaghan, P. D., Long, L. E., Arnold, J. C., Gunasekaran, N., Thompson, M. R., Dawson, B., Mallet, P. E., Kashem, M. A., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301475 · Cited by 290
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., & Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci25483 · Cited by 290
Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory
Orr, A. G., Hsiao, E. C., Wang, M. M., Ho, K., Kim, D. H., Wang, X., Guo, W., Kang, J., Yu, G.-Q., Adame, A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3930 · Cited by 289
30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Schwarzer, C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.006 · Cited by 289
The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
Döring, Y., Pawig, L., Weber, C., & Noels, H. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00212 · Cited by 289
Choose your partners: dimerization in eukaryotic transcription factors
Amoutzias, G. D., Robertson, D. L., Van de Peer, Y., & Oliver, S. G. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.02.002 · Cited by 289
The role of G protein-coupled receptors in the pathology of Alzheimer's disease
Thathiah, A., & De Strooper, B. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2977 · Cited by 288
Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice
Braunersreuther, V., Zernecke, A., Arnaud, C., Liehn, E. A., Steffens, S., Shagdarsuren, E., Bidzhekov, K., Burger, F., Pelli, G., Luckow, B., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000253886.44609.ae · Cited by 288
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Xiong, W., Cui, T., Cheng, K., Yang, F., Chen, S.-R., Willenbring, D., Guan, Y., Pan, H.-L., Ren, K., Xu, Y., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120242 · Cited by 288
Gain-of-function mutations in sodium channel NaV1.9 in painful neuropathy
Huang, J., Han, C., Estacion, M., Vasylyev, D., Hoeijmakers, J. G. J., Gerrits, M. M., Tyrrell, L., Lauria, G., Faber, C. G., Dib-Hajj, S. D., et al. (2014) · Brain · doi:10.1093/brain/awu079 · Cited by 288
Fraser, G. A. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00071.x · Cited by 283
Nadal, A., Alonso-Magdalena, P., Soriano, S., Quesada, I., & Ropero, A. B. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.016 · Cited by 287
Wang, S., Dai, Y., Fukuoka, T., Yamanaka, H., Kobayashi, K., Obata, K., Cui, X., Tominaga, M., & Noguchi, K. (2008) · Brain · doi:10.1093/brain/awn060 · Cited by 285
Acid-Sensitive Ion Channels and Receptors
Holzer, P. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-79090-7_9 · Cited by 282
Neurotoxins and Their Binding Areas on Voltage-Gated Sodium Channels
Stevens, M., Peigneur, S., & Tytgat, J. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00071 · Cited by 282
Jones, R. L., Hannan, N. J., Kaitu’u, T. J., Zhang, J., & Salamonsen, L. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0507 · Cited by 281
McDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M., Cupples, L. A., Merrell, M. N., Wilson, P. W. F., D’Agostino, R. B., O’Donnell, C. J., Patel, D. D., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16790 · Cited by 281
Nicotinic acetylcholine receptors as targets for antidepressants
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279
The neuronal genome of Caenorhabditis elegans
Hobert, O. (2013) · WormBook · doi:10.1895/wormbook.1.161.1 · Cited by 279
Light, A. R., Hughen, R. W., Zhang, J., Rainier, J., Liu, Z., & Lee, J. (2008) · Journal of Neurophysiology · doi:10.1152/jn.01344.2007 · Cited by 277
Pin, J.-P., Neubig, R., Bouvier, M., Devi, L., Filizola, M., Javitch, J. A., Lohse, M. J., Milligan, G., Palczewski, K., Parmentier, M., et al. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.1.5 · Cited by 277
Self-citationEvolutionary origins of the purinergic signalling system
Burnstock, G., & Verkhratsky, A. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01957.x · Cited by 277
Structural and functional evolution of vertebrate neuroendocrine stress systems
Denver, R. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04433.x · Cited by 273
The Pathogenesis of Pterygium: Current Concepts and Their Therapeutic Implications
Chui, J., Girolamo, N. D., Wakefield, D., & Coroneo, M. T. (2008) · The Ocular Surface · doi:10.1016/s1542-0124(12)70103-9 · Cited by 276
The two-pore channel TPCN2 mediates NAADP-dependent Ca2+-release from lysosomal stores
Zong, X., Schieder, M., Cuny, H., Fenske, S., Gruner, C., Rötzer, K., Griesbeck, O., Harz, H., Biel, M., & Wahl-Schott, C. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0690-y · Cited by 275
Ca2+-Activated K+Channels: From Protein Complexes to Function
Berkefeld, H., Fakler, B., & Schulte, U. (2010) · Physiological Reviews · doi:10.1152/physrev.00049.2009 · Cited by 274
Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo
Oschatz, C., Maas, C., Lecher, B., Jansen, T., Björkqvist, J., Tradler, T., Sedlmeier, R., Burfeind, P., Cichon, S., Hammerschmidt, S., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.008 · Cited by 273
Takayama, H., Ishikawa, H., Kurihara, M., Kitajima, M., Aimi, N., Ponglux, D., Koyama, F., Matsumoto, K., Moriyama, T., Yamamoto, L. T., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010576e · Cited by 273
Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice
Jin, K., Xie, L., Kim, S. H., Parmentier-Batteur, S., Sun, Y., Mao, X. O., Childs, J., & Greenberg, D. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.2.204 · Cited by 273
Estrogen accelerates the resolution of inflammation in macrophagic cells
Villa, A., Rizzi, N., Vegeto, E., Ciana, P., & Maggi, A. (2015) · Scientific Reports · doi:10.1038/srep15224 · Cited by 272
Moreira, F. A., Grieb, M., & Lutz, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.003 · Cited by 272
From genes to pain: Nav1.7 and human pain disorders
Dib-Hajj, S. D., Cummins, T. R., Black, J. A., & Waxman, S. G. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.08.004 · Cited by 272
Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets
Ulven, T. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00111 · Cited by 271
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
Massi, P., Vaccani, A., Ceruti, S., Colombo, A., Abbracchio, M. P., & Parolaro, D. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061002 · Cited by 271
Bíró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.004 · Cited by 271
Tumour–induced immune modulation of sentinel lymph nodes
Cochran, A. J., Huang, R.-R., Lee, J., Itakura, E., Leong, S. P. L., & Essner, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1919 · Cited by 268
Regulation of nausea and vomiting by cannabinoids
Parker, L. A., Rock, E. M., & Limebeer, C. L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01176.x · Cited by 268
A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology
Eubanks, L. M., Rogers, C. J., Beuscher, Koob, G. F., Olson, A. J., Dickerson, T. J., & Janda, K. D. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060066m · Cited by 268
Molecular Determinants of KCNQ (Kv7) K+Channel Sensitivity to the Anticonvulsant Retigabine
Schenzer, A., Friedrich, T., Pusch, M., Saftig, P., Jentsch, T. J., Grötzinger, J., & Schwake, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0128-05.2005 · Cited by 267
Activation of RXR–PPAR heterodimers by organotin environmental endocrine disruptors
le Maire, A., Grimaldi, M., Roecklin, D., Dagnino, S., Vivat‐Hannah, V., Balaguer, P., & Bourguet, W. (2009) · EMBO reports · doi:10.1038/embor.2009.8 · Cited by 266
Adenosine Receptors and the Central Nervous System
Sebastião, A. M., & Ribeiro, J. A. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-89615-9_16 · Cited by 266
Towards Fish Lipid Nutrigenomics: Current State and Prospects for Fin-Fish Aquaculture
Leaver, M. J., Bautista, J. M., Björnsson, B. T., Jönsson, E., Krey, G., Tocher, D. R., & Torstensen, B. E. (2008) · Reviews in Fisheries Science · doi:10.1080/10641260802325278 · Cited by 265
Sugimoto, N., Takuwa, N., Okamoto, H., Sakurada, S., & Takuwa, Y. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1534-1545.2003 · Cited by 264
Organ selectivity in metastasis: regulation by chemokines and their receptors
Ben-Baruch, A. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9097-3 · Cited by 264
Loss of functional GABA A receptors in the Alzheimer diseased brain
Limon, A., Reyes-Ruiz, J. M., & Miledi, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204606109 · Cited by 264
Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes
Smith, N. J., & Milligan, G. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002667 · Cited by 262
Wuttke, T. V., Seebohm, G., Bail, S., Maljevic, S., & Lerche, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010793 · Cited by 262
Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1α
Chevaleyre, V., Heifets, B. D., Kaeser, P. S., Südhof, T. C., & Castillo, P. E. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.020 · Cited by 261
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Ryzhov, S., Novitskiy, S. V., Goldstein, A. E., Biktasova, A., Blackburn, M. R., Biaggioni, I., Dikov, M. M., & Feoktistov, I. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101225 · Cited by 261
Carvacrol, a component of thyme oil, activates PPARα and γ and suppresses COX-2 expression
Hotta, M., Nakata, R., Katsukawa, M., Hori, K., Takahashi, S., & Inoue, H. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m900255-jlr200 · Cited by 260
Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Lester, D. B., Rogers, T. D., & Blaha, C. D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00142.x · Cited by 259
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
The multifaceted roles of chemokines in malignancy
Ben-Baruch, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9003-5 · Cited by 259
PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
Corona, J. C., & Duchen, M. R. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.023 · Cited by 259
The Frizzled family of unconventional G-protein-coupled receptors
Schulte, G., & Bryja, V. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.09.001 · Cited by 253
Prossnitz, E. R., & Arterburn, J. B. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009712 · Cited by 258
PPARγ-Activating Angiotensin Type-1 Receptor Blockers Induce Adiponectin
Clasen, R., Schupp, M., Foryst-Ludwig, A., Sprang, C., Clemenz, M., Krikov, M., Thöne-Reineke, C., Unger, T., & Kintscher, U. (2005) · Hypertension · doi:10.1161/01.hyp.0000168046.19884.6a · Cited by 257
CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
Dhopeshwarkar, A., & Mackie, K. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094649 · Cited by 257
Guilluy, C., Brégeon, J., Toumaniantz, G., Rolli-Derkinderen, M., Retailleau, K., Loufrani, L., Henrion, D., Scalbert, E., Bril, A., Torres, R. M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2079 · Cited by 256
Histamine in the immune regulation of allergic inflammation
Akdis, C. A., & Blaser, K. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1585 · Cited by 256
The chemokine system – a major regulator of angiogenesis in health and disease
ROSENKILDE, M. M., & SCHWARTZ, T. W. (2004) · APMIS · doi:10.1111/j.1600-0463.2004.apm11207-0808.x · Cited by 255
Targeted anticancer therapy: Overexpressed receptors and nanotechnology
Akhtar, M. J., Ahamed, M., Alhadlaq, H. A., Alrokayan, S. A., & Kumar, S. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.05.004 · Cited by 255
Drosophila HNF4 Regulates Lipid Mobilization and β-Oxidation
Palanker, L., Tennessen, J. M., Lam, G., & Thummel, C. S. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.009 · Cited by 255
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Blázquez, C., González-Feria, L., Álvarez, L., Haro, A., Casanova, M. L., & Guzmán, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3927 · Cited by 255
Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain
Alfonso-Loeches, S., & Guerri, C. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.580567 · Cited by 254
Sarkar, J., Wakefield, S., MacKenzie, G., Moss, S. J., & Maguire, J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2560-11.2011 · Cited by 254
Lewis, D., Volk, D., & Hashimoto, T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1673-x · Cited by 253
Sitkovsky, M. V., Kjaergaard, J., Lukashev, D., & Ohta, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0229 · Cited by 253
Stow, L. R., Jacobs, M. E., Wingo, C. S., & Cain, B. D. (2011) · The FASEB Journal · doi:10.1096/fj.10-161612 · Cited by 253
Metadata
- Authors
- Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 55
- Issue
- 4
- Pages
- 573-574
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2106607972
- Cited by
- 7,126
- References
- 2
- FWCI
- 162.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.